Life Quality Gains Evident With Newer Preventive HAE Therapies, Survey Finds

Life Quality Gains Evident With Newer Preventive HAE Therapies, Survey Finds

291605

Life Quality Gains Evident With Newer Preventive HAE Therapies, Survey Finds

Newer preventive therapies for hereditary angioedema (HAE) lead to a better quality of life and fewer attacks than on-demand treatments, according to a large patient survey study. The study, “Assessing the cost and quality-of-life impact of on-demand‐only medications for adults with hereditary angioedema,” carried out by the U.S. HAE Association and HAE International (HAEi), was published in the journal Allergy & Asthma Proceedings. Modern preventive medications, such Takhzyro (lanadelumab) and Haegarda, are designed to stop…

You must be logged in to read/download the full post.